Critical Care

official impact factor 4.60

Open Access Highly Access Research

Offset of pharmacodynamic effects and safety of remifentanil in intensive care unit patients with various degrees of renal impairment

Des Breen*, Alexander Wilmer, Andrew Bodenham, Vagn Bach, Jan Bonde, Paul Kessler, Sven Albrecht and Soraya Shaikh

Critical Care 2004, 8:R21-R30 doi:10.1186/cc2399


See related Commentary: http://ccforum.com/content/8/1/13

No comments have yet been made on this article.

Post a comment